These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 21527652)

  • 1. Increased cyclosporine concentrations in the absence of cyclosporine administration.
    Peter A; Shipkova M; Wieland E; Schleicher E; Müller I
    Clin Chem; 2011 May; 57(5):670-3. PubMed ID: 21527652
    [No Abstract]   [Full Text] [Related]  

  • 2. Commentary.
    Milone MC
    Clin Chem; 2011 May; 57(5):674. PubMed ID: 21527654
    [No Abstract]   [Full Text] [Related]  

  • 3. Commentary.
    Butch AW
    Clin Chem; 2011 May; 57(5):673. PubMed ID: 21527653
    [No Abstract]   [Full Text] [Related]  

  • 4. False increase in C-reactive protein attributable to heterophilic antibodies in two renal transplant patients treated with rabbit antilymphocyte globulin.
    Benoist JF; Orbach D; Biou D
    Clin Chem; 1998 Sep; 44(9):1980-5. PubMed ID: 9732987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclosporine therapy in pancreas transplantation.
    Davidson I; Lu C; Melone D; Risser R
    Transplant Proc; 1996 Aug; 28(4):2134-5. PubMed ID: 8769179
    [No Abstract]   [Full Text] [Related]  

  • 6. Neoral dose monitoring with cyclosporine 2-hour postdose levels in heart transplant patients receiving anti-thymocyte globulin induction.
    Cantarovich M; Quantz M; Elstein E; Ergina P; Magnan C; de Varennes B
    Transplant Proc; 2000 Mar; 32(2):446-8. PubMed ID: 10715475
    [No Abstract]   [Full Text] [Related]  

  • 7. Case studies: conversion from Sandimmune to Neoral in stable renal allograft recipients.
    Roth D; Miller J
    Transplant Proc; 1996 Aug; 28(4):2219-20; discussion 2218. PubMed ID: 8769204
    [No Abstract]   [Full Text] [Related]  

  • 8. Neuropathy of metachromatic leukodystrophy: improvement with immunomodulation.
    Nevo Y; Pestronk A; Lopate G; Carroll SL
    Pediatr Neurol; 1996 Oct; 15(3):237-9. PubMed ID: 8916163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Falsely elevated whole blood cyclosporine concentrations measured by an immunoassay with automated pretreatment.
    Bartoli A; Molinaro M; Visai L
    Ther Drug Monit; 2010 Dec; 32(6):791-2. PubMed ID: 21068651
    [No Abstract]   [Full Text] [Related]  

  • 10. Enhanced efficacy of repeated anti-CD8 monoclonal antibody therapy by high-dose cyclosporine treatment.
    Allan JS; Slisz JK; Vesga L; Arn JS; Yamada K; Sachs DH; Madsen JC
    Transplant Proc; 1998 Dec; 30(8):4062-3. PubMed ID: 9865295
    [No Abstract]   [Full Text] [Related]  

  • 11. A study of tolerance in a concordant xenograft model.
    Bartholomew AM; Cosimi AB; Sachs DH; Bailin M; Boskovic S; Colvin R; Hong H; Johnson M; Kimikawa M; Leguern A; Meehan S; Sablinski T; Wee SL; Powelson J
    Transplant Proc; 1997; 29(1-2):923-4. PubMed ID: 9123588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Falsely increased blood tacrolimus concentrations using the ACMIA assay due to circulating endogenous antibodies in a liver transplant recipient: a tentative approach to obtaining reliable results.
    Hermida J; Tutor JC
    Ther Drug Monit; 2009 Apr; 31(2):269-72. PubMed ID: 19258927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apparent elevation of cyclosporine whole blood concentrations in a renal allograft recipient.
    de Jonge H; Geerts I; Declercq P; de Loor H; Claes K; Desmet K; Kuypers DR
    Ther Drug Monit; 2010 Oct; 32(5):529-31. PubMed ID: 20625351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies in the treatment of aplastic anemia.
    Gómez-Almaguer D; Jaime-Pérez JC; Ruiz-Arguelles GJ
    Arch Immunol Ther Exp (Warsz); 2012 Apr; 60(2):99-106. PubMed ID: 22307362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abbreviated cyclosporine pharmacokinetic profiling in clinical renal transplantation: from principles to practice.
    Vathsala A; Lu YM
    Transplant Proc; 2001; 33(7-8):3137-9. PubMed ID: 11750348
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of cyclosporine pharmacokinetic profiles in an antibody induction protocol reduces early acute rejection rates in recipients of primary cadaveric renal allografts.
    Lewis R; Coutee J; Steinmuller D; Hatch D; Manion S; Agrawal R; Moel D; Flanigan R
    Transplant Proc; 1997; 29(1-2):294-5. PubMed ID: 9123002
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug monitoring of mycophenolic acid in the early period after renal transplantation.
    Krumme B; Wollenberg K; Kirste G; Schollmeyer P
    Transplant Proc; 1998 Aug; 30(5):1773-4. PubMed ID: 9723276
    [No Abstract]   [Full Text] [Related]  

  • 18. Cyclosporine A blood levels predict acute rejections as well as cyclosporine A toxicity after simultaneous pancreas-kidney transplantation.
    Dawidson I; Ar'Rajab A; Lu C; Melone D; Provost D; Wheeler D
    Transplant Proc; 1994 Oct; 26(5):2757-8. PubMed ID: 7940868
    [No Abstract]   [Full Text] [Related]  

  • 19. Induction therapy with bolus ATG increases cyclosporine sensitivity in renal transplant recipients.
    Varghese Z; Abudher MN; Fernando ON; Moorhead JF
    Transplant Proc; 2001 May; 33(3):2251-3. PubMed ID: 11377518
    [No Abstract]   [Full Text] [Related]  

  • 20. [The use of allogeneic bone marrow transplantation and immunosuppressive therapy in the treatment of patients with acquired aplastic anemia].
    Ganapiev AA; Golubovskaia IK; Zalialov IuR; Estrina MA; Afanas'ev BV
    Ter Arkh; 2010; 82(7):48-52. PubMed ID: 20853609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.